INDOCO258.00

Indoco Remedies Limited

· Pharma & Health
₹ CrorePeersSAIPARENTPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,381 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
INDOCO
FY26
SAIPARENT
FY26
PANACEABIO
FY26
HIKAL
FY26
Peer
Median
Valuation — at last close
P/E119.50×119.50×
P/B2.55×4.65×2.87×2.41×2.87× -11%
EV/EBITDA23.92×56.96×-501.02×16.16×16.16× +48%
Market Cap₹2,381 Cr₹2,302 Cr₹2,378 Cr₹2,891 Cr₹2,378 Cr +0%
Growth
Revenue CAGR 3Y3.41%11.63%-5.40%3.12% +9%
Revenue CAGR 5Y8.25%0.47%-0.09%0.19% +4242%
Revenue YoY (latest Q)6.76%19.72%5.89%12.80% -47%
Net Income YoY (latest Q)280.03%-44.44%66.96%11.26% +2387%
Profitability
EBITDA Margin7.68%10.16%-0.73%12.87%10.16% -24%
Net Income Margin-5.35%3.74%-1.12%-2.85%-1.12% -378%
Return on Common Equity-10.21%2.88%-0.65%-4.07%-0.65% -1471%
Return on Capital Employed1.00%2.57%-4.13%3.36%2.57% -61%
Return on Assets-3.81%1.00%-0.57%-2.06%-0.57% -568%
Credit & Quality
Total Debt/Equity1.11×0.65×0.03×0.57×0.57× +95%
Interest Coverage0.13×1.18×-6.23×0.91×0.91× -86%
Scale — latest FY
Revenue / Total Income₹1,845 Cr₹381 Cr₹640 Cr₹1,713 Cr₹640 Cr +188%
Net Income−₹98.7 Cr₹14.3 Cr−₹7.2 Cr−₹48.8 Cr−₹7.2 Cr -1278%
Total Assets₹2,593 Cr₹1,424 Cr₹1,262 Cr₹2,365 Cr₹1,424 Cr +82%
EPS₹-10.7₹4.36₹-0.88₹-3.96₹-0.88 -1116%
Book Value per Share₹100.99₹112.07₹135.22₹97.07₹112.07 -10%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.